Integrated Neuromuscular Inhibition, Muscle Energy and Strain Counter Strain Techniques in Neck Pain
CompletedNot applicableNCT05262062
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
1. To determine effects of Neuromuscular Inhibition, Muscle energy and strain counter strain techniques on Pain, disability, pain pressure threshold, range of motion, and health-related quality of life in mechanical neck pain. 2. To compare the effects of Integrated Neuromuscular inhibition, Muscle energy and strain counter strain techniques in the Management of mechanical neck pain.
Study details
- Official title
- Effect of Integrated Neuromuscular Inhibition, Muscle Energy and Strain Counter Strain Techniques in the Management of Mechanical Neck Pain.
- Conditions
- Interventions
- Other: Strain Counter Strain Technique
- Other: Muscle Energy Technique,
- Other: Integrated Neuromuscular Inhibition Technique
- Sponsor
- Riphah International University
- Start date
- 2021-10-25
- Primary completion
- 2022-03-24
- Sex
- All
- Age range
- from 30 Years to 60 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Pakistan
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Participants falling in this category would be recruited into the study. * Patients with chronic mechanical neck pain (symptoms for more than 3 months). * Age group between 30 - 60 years. * Patients willing to participate and take treatment. * Patients must have at least 1 active trigger point at upper trapezius, levator scapulae, SCM. * Gender (Both) * VAS \>3 Exclusion Criteria: * • Patients having severe neck pain. * Patients having any systemic joint pathology, inflammatory joint disease (e.g rheumatoid arthritis, gouty arthritis, psoriatic arthritis). * Patients who had any neurological deficit, myelopathy any mental illness. * Patients on medication like antidepressants, corticosteroid, anti-inflammatory medications.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05262062